Dr. Trushina is a Professor in the Department of Neurology at the Mayo Clinic. She received her doctoral degree in chemistry from Saratov State University, Russia. Dr. Trushina completed her postdoctoral training studying redox chemistry and mechanisms of mitochondrial dynamics and function in Huntington's Disease. Dr. Trushina's translational research program is focused on the mechanisms of neurodegenerative diseases, particularly as they intersect with studies on aging and metabolic disorders, and the development of mitochondria-targeted therapeutics. Her group developed neuroprotective treatment for Alzheimer's Disease, which is now in the lead optimization and preclinical characterization stage. Dr. Trushina is a recipient of the NIH NINDS, NIA, NIEHS, BrightFocus, GHR, ADDF, and Mayo Clinic Research Awards.
